Development of inhibitors as research tools for carbohydrate-processing enzymes

Biochemical Society Transactions

Volumn 40, Issue 5, 2012, Pages 913-928

  Gloster, Tracey M ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Carbohydrate processing enzyme; Glycan; Glycoside hydrolase; Glycosyltransferase; Inhibition

Indexed keywords

1 DEOXYNOJIRIMYCIN; ACARBOSE; CARBOHYDRATE; CERAMIDE GLUCOSYLTRANSFERASE; ENZYME INHIBITOR; GLYCAN; GLYCOLIPID; GLYCOPROTEIN; GLYCOSIDASE INHIBITOR; GLYCOSYLTRANSFERASE INHIBITOR; ISOFAGOMINE; MIGLITOL; MIGLUSTAT; N ACETYLGLUCOSAMINE; OSELTAMIVIR; OXAZINE DERIVATIVE; PROTEOGLYCAN; UNCLASSIFIED DRUG; VIRUS SIALIDASE; VOGLIBOSE;

CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; CHEMICAL STRUCTURE; GAUCHER DISEASE; GLYCOSYLATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHASE TRANSITION; PRIORITY JOURNAL; REVIEW; STEREOCHEMISTRY;

CARBOHYDRATE METABOLISM; ENZYME INHIBITORS; GLYCOSIDE HYDROLASES; GLYCOSYLTRANSFERASES; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866672914     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120201     Document Type: Review

References (121)

1. Sharon, N. (2001) The conquest of the last frontier of molecular and cell biology. Biochimie 83, 555
2. Varki, A. and Lowe, J.B. (2009) Biological roles of glycans. In Essentials of Glycobiology (Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W. and Etzler, M.E., eds), Cold Spring Harbor Laboratory Press, Plainview
3. xoligosaccharide on the zona pellucida. Science 333, 1761-1764
4. Tabak, L.A. (2010) The role of mucin-type O-glycans in eukaryotic development. Semin. Cell Dev. Biol. 21, 616-621
5. Aebi, M., Bernasconi, R., Clerc, S. and Molinari, M. (2010) N-glycan structures: recognition and processing in the ER. Trends Biochem. Sci. 35, 74-82
6. Kim, S.H., Turnbull, J. and Guimond, S. (2011) Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 209, 139-151
7. 12 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 4, 759-767
8. Davies, G.J., Gloster, T.M. and Henrissat, B. (2005) Recent structural insights into the expanding world of carbohydrate-active enzymes. Curr. Opin. Struct. Biol. 15, 637-645
9. Ohtsubo, K. and Marth, J.D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867
10. Thompson, A.J., Williams, R.J., Hakki, Z., Alonzi, D.S., Wennekes, T., Gloster, T.M., Songsrirote, K., Thomas-Oates, J.E., Wrodnigg, T.M., Spreitz, J. et al. (2012) Structural and mechanistic insight into N-glycan processing by endo-α-mannosidase. Proc. Natl. Acad. Sci. U.S.A. 109, 781-786
11. Lau, K.S. and Dennis, J.W. (2008) N-Glycans in cancer progression. Glycobiology 18, 750-760
12. Bischoff, H. (1995) The mechanism of α-glucosidase inhibition in the management of diabetes. Clin. Invest. Med. 18, 303-311
13. Hruska, K.S., LaMarca, M.E., Scott, C.R. and Sidransky, E. (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum. Mutat. 29, 567-583
14. Shuhui, L., Mok, Y.K. and Wong, W.S. (2009) Role of mammalian chitinases in asthma. Int. Arch. Allergy Immunol. 149, 369-377
15. Gamblin, S.J. and Skehel, J.J. (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285, 28403-28409
16. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W. and Gong, C.X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 10804-10809
17. Prescher, J.A. and Bertozzi, C.R. (2006) Chemical technologies for probing glycans. Cell 126, 851-854
18. Vasella, A., Davies, G.J. and Bohm, M. (2002) Glycosidase mechanisms. Curr. Opin. Chem. Biol. 6, 619-629
19. Vocadlo, D.J. and Davies, G.J. (2008) Mechanistic insights into glycosidase chemistry. Curr. Opin. Chem. Biol. 12, 539-555
20. Koshland, Jr, D.E. (1953) Stereochemistry and the mechanism of enzymatic reactions. Biol. Rev. 28, 416-436
21. Sinnott, M.L. (1984) On the antiperiplanar lone pair hypothesis and its application to catalysis by glycosidases. Biochem. J. 224, 817-821
22. Vocadlo, D.J., Davies, G.J., Laine, R. and Withers, S.G. (2001) Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature 412, 835-838
23. Watts, A.G., Damager, I., Amaya, M.L., Buschiazzo, A., Alzari, P., Frasch, A.C. and Withers, S.G. (2003) Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile. J. Am. Chem. Soc. 125, 7532-7533
24. Terwisscha van Scheltinga, A.C., Armand, S., Kalk, K.H., Isogai, A., Henrissat, B. and Dijkstra, B. (1995) Stereochemistry of chitin hydrolysis by a plant chitinase/lysozyme and X-ray structure of a complex with allosamidin: evidence for substrate assisted catalysis. Biochemistry 34, 15619-15623
25. Macauley, M.S., Whitworth, G.E., Debowski, A.W., Chin, D. and Vocadlo, D.J. (2005) O-GlcNAcase uses substrate-assisted catalysis. J. Biol. Chem. 280, 25313-25322
26. Morley, T.J., Willis, L.M., Whitfield, C., Wakarchuk, W.W. and Withers, S.G. (2009) A new sialidase mechanism: bacteriophage K1F endo-sialidase is an inverting glycosidase. J. Biol. Chem. 284, 17404-17410
27. Yip, V.L., Varrot, A., Davies, G.J., Rajan, S.S., Yang, X., Thompson, J., Anderson, W.F. and Withers, S.G. (2004) An unusual mechanism of glycoside hydrolysis involving redox and elimination steps by a family 4 β-glycosidase from Thermotoga maritima. J. Am. Chem. Soc. 126, 8354-8355
28. Cantarel, B.L., Coutinho, P.M., Rancurel, C., Bernard, T., Lombard, V. and Henrissat, B. (2008) The Carbohydrate-Active enZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 37, D233-D238
29. Gloster, T.M., Turkenburg, J.P., Potts, J.R., Henrissat, B. and Davies, G.J. (2008) Divergence of catalytic mechanism within a glycosidase family provides insight into evolution of carbohydrate metabolism by human gut flora. Chem. Biol. 15, 1058-1067
30. Kitamura, M., Okuyama, M., Tanzawa, F., Mori, H., Kitago, Y., Watanabe, N., Kimura, A., Tanaka, I. and Yao, M. (2008) Structural and functional analysis of a glycoside hydrolase family 97 enzyme from Bacteroides thetaiotaomicron. J. Biol. Chem. 283, 36328-36337
31. Okuyama, M., Kitamura, M., Hondoh, H., Kang, M.S., Mori, H., Kimura, A., Tanaka, I. and Yao, M. (2009) Catalytic mechanism of retaining α-galactosidase belonging to glycoside hydrolase family 97. J. Mol. Biol. 392, 1232-1241
32. Pauling, L. (1946) Molecular architecture and biological reactions. Chem. Eng. News 24, 1375-1377
33. Pauling, L. (1948) Nature of forces between large molecules of biological interest. Nature 161, 707-709
34. Wolfenden, R., Lu, X. and Young, G. (1998) Spontaneous hydrolysis of glycosides. J. Am. Chem. Soc. 120, 6814-6815
35. Wolfenden, R. and Snider, M.J. (2001) The depth of chemical time and the power of enzymes as catalysts. Acc. Chem. Res. 34, 938-945
36. Gloster, T.M. and Davies, G.J. (2010) Glycosidase inhibition: assessing mimicry of the transition state. Org. Biomol. Chem. 8, 305-320
37. Kempton, J.B. and Withers, S.G. (1992) Mechanism of Agrobacterium β-glucosidase: kinetic studies. Biochemistry 31, 9961-9969
38. Tull, D. and Withers, S.G. (1994) Mechanisms of cellulases and xylanases: a detailed kinetic study of the exo-β-1,4-glycanase from Cellulomonas fimi. Biochemistry 33, 6363-6370
39. Davies, G.J., Sinnott, M.L. and Withers, S.G. (1998) Glycosyl transfer. In Comprehensive Biological Catalysis: a Mechanistic Reference (Sinnott, M.L., ed.), pp. 119-209, Academic Press, London
40. Sinnott, M.L. (1990) Catalytic mechanisms of enzymatic glycosyl transfer. Chem. Rev. 90, 1171-1202
41. von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Phan, T.V., Smythe, M.L., White, H.F., Oliver, S.W. et al. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423
42. Eisenberg, E.J., Bidgood, A. and Cundy, K.C. (1997) Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104. Antimicrob. Agents Chemother. 41, 1949-1952
43. Collins, P.J., Haire, L.F., Lin, Y.P., Liu, J., Russell, R.J., Walker, P.A., Martin, S.R., Daniels, R.S., Gregory, V., Skehel, J.J. et al. (2009) Structural basis for oseltamivir resistance of influenza viruses. Vaccine 27, 6317-6323
44. Sailer, D. and Roder, G. (1980) Treatment of non-insulin dependent diabetic adults with a new glycoside hydrolase inhibitor (Bay g 5421). Arzneimittelforschung 30, 2182-2185
45. Nahoum, V., Roux, G., Anton, V., Rouge, P., Puigserver, A., Bischoff, H., Henrissat, B. and Payan, F. (2000) Crystal structures of human pancreatic α-amylase in complex with carbohydrate and proteinaceous inhibitors. Biochem. J. 346, 201-208
46. Goke, B., Fuder, H., Wieckhorst, G., Theiss, U., Stridde, E., Littke, T., Kleist, P., Arnold, R. and Lucker, P.W. (1995) Voglibose (AO-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 56, 493-501
47. Joubert, P.H., Bam, W.J. and Manyane, N. (1986) Effect of an α-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics. Eur. J. Clin. Pharmacol. 30, 253-255
48. Lillelund, V.H., Jensen, H.H., Liang, X. and Bols, M. (2002) Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin. Chem. Rev. 102, 515-553
49. Stütz, A.E. (ed.) (1999) Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond, Wiley-VCH, Weinheim
50. Asano, N. (2009) Sugar-mimicking glycosidase inhibitors: bioactivity and application. Cell. Mol. Life Sci. 66, 1479-1492
51. Paulsen, H., Sangster, I. and Heyns, K. (1967) Synthese und Reaktionen von Keto-piperidinosen. Chem. Ber. 100, 802-815
52. Jespersen, T.M., Dong, W., Sierks, M.R., Skrydstrup, T., Lundt, I. and Bols, M. (1994) Isofagomine, a potent, new glycosidase inhibitor. Angew. Chem. Int. Ed. Engl. 33, 1778-1779
53. Hoos, R., Naughton, A.B., Thiel, W., Vasella, A., Weber, W., Rupitz, K. and Withers, S.G. (1993) D-Gluconhydroximo-1,5-lactam and related N-arylcarbamates: theoretical calculations, structure, synthesis, and inhibitory effect on β-glucosidases. Helv. Chim. Acta 76, 2666-2686
54. Papandreou, G., Tong, M.K. and Ganem, B. (1993) Amidine, amidrazone, and amidoxime derivatives of monosaccharide aldonolactams: synthesis and evaluation as glycosidase inhibitors. J. Am. Chem. Soc. 115, 11682-11690
55. Granier, T., Panday, N. and Vasella, A. (1997) Structure-activity relations for imidazo-pyridine-type inhibitors of β-D-glucosidases. Helv. Chim. Acta 80, 979-987
56. Wolfenden, R., Snider, M., Ridgway, C. and Miller, B. (1999) The temperature dependence of enzyme rate enhancements. J. Am. Chem. Soc. 121, 7419-7420
57. Gloster, T.M., Meloncelli, P., Stick, R.V., Zechel, D.L., Vasella, A. and Davies, G.J. (2007) Glycosidase inhibition: an assessment of the binding of eighteen putative transition-state mimics. J. Am. Chem. Soc. 129, 2345-2354
58. Holdgate, G.A. (2001) Making cool drugs hot: isothermal titration calorimetry as a tool to study binding energetics. BioTechniques 31, 164-184
59. Shoichet, B.K., Leach, A.R. and Kuntz, I.D. (1999) Ligand solvation in molecular docking. Proteins 34, 4-16
60. Hernandez Daranas, A., Shimizu, H. and Homans, S.W. (2004) Thermodynamics of binding of D-galactose and deoxy derivatives thereof to the L-arabinose-binding protein. J. Am. Chem. Soc. 126, 11870-11876
61. Cooper, A., Johnson, C.M., Lakey, J.H. and Nöllmann, M. (2001) Heat does not come in different colours: entropy-enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions. Biophys. Chem. 93, 215-230
62. Dunitz, J.D. (1995) Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactions. Chem. Biol. 2, 709-712
63. Varrot, A., Tarling, C.A., Macdonald, J.M., Stick, R.V., Zechel, D.L., Withers, S.G. and Davies, G.J. (2003) Direct observation of the protonation state of an imino sugar glycosidase inhibitor upon binding. J. Am. Chem. Soc. 125, 7496-7497
64. Gloster, T., Williams, S.J., Tarling, C.A., Roberts, S., Dupont, C., Jodoin, P., Shareck, F., Withers, S.G. and Davies, G.J. (2003) A xylobiose-derived isofagomine lactam glycosidase inhibitor binds as its amide tautomer. Chem. Commun., 944-945
65. Davies, G.J., Mackenzie, L., Varrot, A., Dauter, M., Brzozowski, A.M., Schulein, M. and Withers, S.G. (1998) Snapshots along an enzymatic reaction coordinate: analysis of a retaining β-glycoside hydrolase. Biochemistry 37, 11707-11713
66. Ducros, V.M., Zechel, D.L., Murshudov, G.N., Gilbert, H.J., Szabo, L., Stoll, D., Withers, S.G. and Davies, G.J. (2002) Substrate distortion by a β-mannanase: snapshots of the Michaelis and covalent-intermediate complexes suggest a B2,5 conformation for the transition state. Angew. Chem. Int. Ed. 41, 2824-2827
67. He, Y., Macauley, M.S., Stubbs, K.A., Vocadlo, D.J. and Davies, G.J. (2010) Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J. Am. Chem. Soc. 132, 1807-1809
68. Davies, G.J., Planas, A. and Rovira, C. (2012) Conformational analyses of the reaction coordinate of glycosidases. Acc. Chem. Res. 45, 308-316
69. Davies, G.J., Ducros, V.M.-A., Varrot, A. and Zechel, D.L. (2003) Mapping the conformational itinerary of β-glycosidases by X-ray crystallography. Biochem. Soc. Trans. 31, 523-527
70. Tailford, L.E., Offen, W.A., Smith, N.L., Dumon, C., Morland, C., Gratien, J., Heck, M.P., Stick, R.V., Bleriot, Y., Vasella, A. et al. (2008) Structural and biochemical evidence for a boat-like transition state in β-mannosidases. Nat. Chem. Biol. 4, 306-312
71. Gloster, T.M., Macdonald, J.M., Tarling, C.A., Stick, R.V., Withers, S.G. and Davies, G.J. (2004) Structural, thermodynamic and kinetic analyses of tetrahydrooxazine-derived inhibitors bound to β-glucosidases. J. Biol. Chem. 279, 49236-49242
72. Zechel, D.L., Boraston, A.B., Gloster, T., Boraston, C.M., Macdonald, J.M., Tilbrook, D.M.G., Stick, R.V. and Davies, G.J. (2003) Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to β-glucosidases. J. Am. Chem. Soc. 125, 14313-14323
73. Gloster, T.M., Roberts, S., Perugino, G., Rossi, M., Moracci, M., Panday, N., Terinek, M., Vasella, A. and Davies, G.J. (2006) Structural, kinetic and thermodynamic analysis of glucoimidazole-derived glycosidase inhibitors. Biochemistry 45, 11879-11884
74. Hrmova, M., Streltsov, V.A., Smith, B.J., Vasella, A., Vargese, J.N. and Fincher, G.B. (2005) Structural rationale for low-nanomolar binding of transition state mimics to a family GH3 β-D-glucan glucohydrolase from barley. Biochemistry 44, 16529-16539
75. Dale, M.P., Ensley, H.E., Kern, K., Sastry, K.A.R. and Byers, L.D. (1985) Reversible inhibitors of β-glucosidase. Biochemistry 24, 3530-3539
76. Axamawaty, M.T.H., Fleet, G.W.J., Hannah, K.A., Namgoong, S.K. and Sinnott, M.L. (1990) Inhibition of the α-L-arabinofuranosidase III of Monilinia fructigena by 1,4-dideoxy-1,4-imino-L-threitol and 1,4-dideoxy-1,4-imino-L-arabinitol. Biochem. J. 266, 245-249
77. Knowles, J.R. (1976) The intrinsic pKa-values of functional groups in enzymes: improper deductions from the pH-dependence of steady-state parameters. Crit. Rev. Biochem. 4, 165-173
78. 13C-NMR study of Bacillus circulans xylanase. Biochemistry 35, 9958-9966
79. Mader, M.M. and Bartlett, P.A. (1997) Binding energy and catalysis: the implications for transition-state analogs and catalytic antibodies. Chem. Rev. 97, 1281-1301
80. Wicki, J., Williams, S.J. and Withers, S.G. (2007) Transition-state mimicry by glycosidase inhibitors: a critical kinetic analysis. J. Am. Chem. Soc. 129, 4530-4531
81. Whitworth, G.E., Macauley, M.S., Stubbs, K.A., Dennis, R.J., Taylor, E.J., Davies, G.J., Greig, I.R. and Vocadlo, D.J. (2007) Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. J. Am. Chem. Soc. 129, 635-644
82. Mosi, R., Sham, H., Uitdehaag, J.C.M., Ruiterkamp, R., Dijkstra, B.W. and Withers, S.G. (1998) Reassessment of acarbose as a transition state analogue inhibitor of cyclodextrin glycosyltransferase. Biochemistry 37, 17192-17198
83. Berland, C.R., Sigurskjold, B.W., Stoffer, B., Frandsen, T.P. and Svensson, B. (1995) Thermodynamics of inhibitor binding to mutant forms of glucoamylase from Aspergillus niger determined by isothermal titration calorimetry. Biochemistry 34, 10153-10161
84. Steet, R.A., Chung, S., Wustman, B., Powe, A., Do, H. and Kornfeld, S.A. (2006) The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms. Proc. Natl. Acad. Sci. U.S.A. 103, 13813-13818
85. Sun, Y., Liou, B., Xu, Y.H., Quinn, B., Zhang, W., Hamler, R., Setchell, K.D. and Grabowski, G.A. (2012) Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. J. Biol. Chem. 287, 4275-4287
86. Yuzwa, S.A., Macauley, M.S., Heinonen, J.E., Shan, X., Dennis, R.J., He, Y., Whitworth, G.E., Stubbs, K.A., McEachern, E.J., Davies, G.J. and Vocadlo, D.J. (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4, 483-490
87. Yuzwa, S.A., Shan, X., Macauley, M.S., Clark, T., Skorobogatko, Y., Vosseller, K. and Vocadlo, D.J. (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat. Chem. Biol. 8, 393-399
88. Liu, J. and Mushegian, A. (2003) Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci. 12, 1418-1431
89. Igura, M., Maita, N., Kamishikiryo, J., Yamada, M., Obita, T., Maenaka, K. and Kohda, D. (2008) Structure-guided identification of a new catalytic motif of oligosaccharyltransferase. EMBO J. 27, 234-243
90. Lairson, L.L., Henrissat, B., Davies, G.J. and Withers, S.G. (2008) Glycosyltransferases: structures, functions, and mechanisms. Annu. Rev. Biochem. 77, 521-555
91. Gomez, H., Polyak, I., Thiel, W., Lluch, J.M. and Masgrau, L. (2012) Retaining glycosyltransferase mechanism studied by QM/MM methods: lipopolysaccharyl-α-1,4-galactosyltransferase C transfers α-galactose via an oxocarbenium ion-like transition state. J. Am. Chem. Soc. 134, 4743-4752
92. Soya, N., Fang, Y., Palcic, M.M. and Klassen, J.S. (2011) Trapping and characterization of covalent intermediates of mutant retaining glycosyltransferases. Glycobiology 21, 547-552
93. Lee, S.S., Hong, S.Y., Errey, J.C., Izumi, A., Davies, G.J. and Davis, B.G. (2011) Mechanistic evidence for a front-side, SNi-type reaction in a retaining glycosyltransferase. Nat. Chem. Biol. 7, 631-638
94. Muller, B., Schaub, C. and Schmidt, R.R. (1998) Efficient sialyltransferase inhibitors based on transition-state analogues of the sialyl donor. Angew. Chem. Int. Ed. 37, 2893-2897
95. Schworer, R. and Schmidt, R.R. (2002) Efficient sialyltransferase inhibitors based on glycosides of N-acetylglucosamine. J. Am. Chem. Soc. 124, 1632-1637
96. Schaub, C., Muller, B. and Schmidt, R.R. (1998) New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay. Glycoconjugate J. 15, 345-354
97. Lee, L.V., Mitchell, M.L., Huang, S.J., Fokin, V.V., Sharpless, K.B. and Wong, C.H. (2003) A potent and highly selective inhibitor of human α-1,3-fucosyltransferase via click chemistry. J. Am. Chem. Soc. 125, 9588-9589
98. Norris, A.J., Whitelegge, J.P., Faull, K.F. and Toyokuni, T. (2001) Kinetic characterization of enzyme inhibitors using electrospray-ionization mass spectrometry coupled with multiple reaction monitoring. Anal. Chem. 73, 6024-6029
99. Norris, A.J., Whitelegge, J.P., Strouse, M.J., Faull, K.F. and Toyokuni, T. (2004) Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism. Bioorg. Med. Chem. Lett. 14, 571-573
100. Palcic, M.M., Heerze, L.D., Srivastava, O.P. and Hindsgaul, O. (1989) A bisubstrate analog inhibitor for α(1-2)-fucosyltransferase. J. Biol. Chem. 264, 17174-17181
101. Izumi, M., Wada, K., Yuasa, H. and Hashimoto, H. (2005) Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities. J. Org. Chem. 70, 8817-8824
102. Hanashima, S., Inamori, K., Manabe, S., Taniguchi, N. and Ito, Y. (2006) Systematic synthesis of bisubstrate-type inhibitors of N- acetylglucosaminyltransferases. Chemistry 12, 3449-3462
103. Errey, J.C., Lee, S.S., Gibson, R.P., Martinez Fleites, C., Barry, C.S., Jung, P.M., O'Sullivan, A.C., Davis, B.G. and Davies, G.J. (2010) Mechanistic insight into enzymatic glycosyl transfer with retention of configuration through analysis of glycomimetic inhibitors. Angew. Chem. Int. Ed. 49, 1234-1237
104. Pesnot, T., Jorgensen, R., Palcic, M.M. and Wagner, G.K. (2010) Structural and mechanistic basis for a new mode of glycosyltransferase inhibition. Nat. Chem. Biol. 6, 321-323
105. Schaefer, K., Albers, J., Sindhuwinata, N., Peters, T. and Meyer, B. (2012) A new concept for glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the human blood group B galactosyltransferase. ChemBioChem. 13, 443-450
106. Platt, F.M., Neises, G.R., Dwek, R.A. and Butters, T.D. (1994) N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269, 8362-8365
107. Takatsuki, A. and Tamura, G. (1971) Tunicamycin, a new antibiotic. II. Some biological properties of the antiviral activity of tunicamycin. J. Antibiot. 24, 224-231
108. Mahoney, W.C. and Duksin, D. (1979) Biological activities of the two major components of tunicamycin. J. Biol. Chem. 254, 6572-6576
109. Lee, K.Y., Kim, H.G., Hwang, M.R., Chae, J.I., Yang, J.M., Lee, Y.C., Choo, Y.K., Lee, Y.I., Lee, S.S. and Do, S.I. (2002) The hexapeptide inhibitor of Galβ1,3GalNAc-specific α2,3-sialyltransferase as a generic inhibitor of sialyltransferases. J. Biol. Chem. 277, 49341-49351
110. Chang, K.H., Lee, L., Chen, J. and Li, W.S. (2006) Lithocholic acid analogues, new and potent α-2,3-sialyltransferase inhibitors. Chem. Commun. 629-631
111. Chiang, C.H., Wang, C.H., Chang, H.C., More, S.V., Li, W.S. and Hung, W.C. (2010) A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. J. Cell. Physiol. 223, 492-499
112. Hart, G.W., Housley, M.P. and Slawson, C. (2007) Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022
113. Gloster, T.M., Zandberg, W.F., Heinonen, J.E., Shen, D.L., Deng, L. and Vocadlo, D.J. (2011) Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. Nat. Chem. Biol. 7, 174-181
114. Dehennaut, V., Lefebvre, T., Sellier, C., Leroy, Y., Gross, B., Walker, S., Cacan, R., Michalski, J.C., Vilain, J.P. and Bodart, J.F. (2007) O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J. Biol. Chem. 282, 12527-12536
115. Caldwell, S.A., Jackson, S.R., Shahriari, K.S., Lynch, T.P., Sethi, G., Walker, S., Vosseller, K. and Reginato, M.J. (2010) Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 29, 2831-2842
116. Shi, Y., Tomic, J., Wen, F., Shaha, S., Bahlo, A., Harrison, R., Dennis, J.W., Williams, R., Gross, B.J., Walker, S. et al. (2010) Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 24, 1588-1598
117. Rillahan, C.D., Antonopoulos, A., Lefort, C.T., Sonon, R., Azadi, P., Ley, K., Dell, A., Haslam, S.M. and Paulson, J.C. (2012) Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat. Chem. Biol. 8, 661-668
118. Kuntz, D.A., Tarling, C.A., Withers, S.G. and Rose, D.R. (2008) Structural analysis of Golgi α-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen. Biochemistry 47, 10058-10068
119. Tarling, C.A., Woods, K., Zhang, R., Brastianos, H.C., Brayer, G.D., Andersen, R.J. and Withers, S.G. (2008) The search for novel human pancreatic α-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts. ChemBioChem 9, 433-438
120. Hosoguchi, K., Maeda, T., Furukawa, J., Shinohara, Y., Hinou, H., Sekiguchi, M., Togame, H., Takemoto, H., Kondo, H. and Nishimura, S. (2010) An efficient approach to the discovery of potent inhibitors against glycosyltransferases. J. Med. Chem. 53, 5607-5619
121. Gross, B.J., Kraybill, B.C. and Walker, S. (2005) Discovery of O-GlcNAc transferase inhibitors. J. Am. Chem. Soc. 127, 14588-14589